Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03390283 · ClinicalTrials.gov registry record
A Survey of Parent/Caregiver Practices on the Storage, Use, and Disposal of Opioids in a Comprehensive Cancer Center
A clinical trial of Malignant Neoplasm and Caregiver, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 115
- Enrollment target
- 1
- Study location
NCT03390283 is a study of Malignant Neoplasm and Caregiver that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 115 participants, below the 511-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03390283, a study of Malignant Neoplasm and Caregiver, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial uses a survey to study parent and caregiver practices on the storage, use, and disposal of opioids in a comprehensive cancer center. It is not known if parents and/or caregivers are aware of the guidelines and recommendations for proper and safe disposal of opioids. This survey will help health care providers assess the needs and improve the safety of patients and their families from the potential dangers of misuse and abuse of prescription opioid medications.
Conditions Studied
Interventions
- OTHER Survey Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2017-12-20 |
| Est. Completion | 2023-11-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03390283
The ClinicalTrials.gov registry entry for NCT03390283 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 511-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (77% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Survey Administration is the first listed.
NCT03390283 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03390283 about?
NCT03390283 is a clinical study titled "A Survey of Parent/Caregiver Practices on the Storage, Use, and Disposal of Opioids in a Comprehensive Cancer Center". This trial uses a survey to study parent and caregiver practices on the storage, use, and disposal of opioids in a comprehensive cancer center. It is not known if parents and/or caregivers are aware of the guidelines and recommendations for proper and safe disposal of opioids. This survey will help ...
What is the current status of trial NCT03390283?
This trial is currently completed. The enrollment target is 115 participants. The study started on 2017-12-20. Estimated completion is 2023-11-17.
What conditions does trial NCT03390283 study?
This clinical trial studies the following conditions: Malignant Neoplasm, Caregiver.
What interventions are being tested in trial NCT03390283?
The interventions under investigation include: Survey Administration (OTHER).
Who is sponsoring clinical trial NCT03390283?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03390283 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
RECRUITING · Phase 1
-
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
RECRUITING · Phase 3
-
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
RECRUITING
-
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RECRUITING · Phase 1
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.